Talbert House

Talbert House is an addiction-treatment facility located in Cincinnati, OH. The facility offers specific levels of care: Inpatient, MAT. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Talbert House

The care-level question matters because what a facility offers is what it can realistically treat well. The facility's documented care levels are The facility offers specific levels of care: Inpatient, MAT. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Talbert House's offerings match the clinical need.

Insurance and payment

On insurance specifically: Talbert House accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Young adults, Adult men, Seniors or older adults. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Before admission to Talbert House, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.